Osmotherapy for malignant cerebral edema in a phase 2 prospective, double blind, randomized, placebo-controlled study of IV glibenclamide-Reference-Cited by-同舟云学术

Osmotherapy for malignant cerebral edema in a phase 2 prospective, double blind, randomized, placebo-controlled study of IV glibenclamide

Published:2020-07 Issue:7 Volume:29 Page:104916
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Hinson H.E.^ORCID,Sun Elizabeth^ORCID,Molyneaux Bradley J.^ORCID,von Kummer Rüdiger^ORCID,Demchuk Andrew,Romero Javier,Taylor Kimberly W.^ORCID,Sheth Kevin N

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,Rehabilitation,Surgery

Reference23 articles.

1. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association;Wijdicks;Stroke,2014

2. Glyburide advantage in malignant edema and stroke (GAMES-RP) trial: rationale and design;Sheth;Neurocrit Care,2016

3. Middle cerebral infarction;Hacke;Arch Neurol,1996

4. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke;Jüttler;N Engl J Med,2014

5. Early external decompressive craniectomy with duroplasty improves functional recovery in patients with massive hemispheric embolic infarction;Mori;Surg Neurol,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirtuins as Potential Targets for Neuroprotection: Mechanisms of Early Brain Injury Induced by Subarachnoid Hemorrhage;Translational Stroke Research;2023-10-02

2. Buffer Coefficient as a Predictor of the Prognosis of Massive Cerebral Infarction;World Neurosurgery;2022-12

3. Medical management of cerebral edema in large hemispheric infarcts;Frontiers in Neurology;2022-11-04

4. Melatonin as a Potential Neuroprotectant: Mechanisms in Subarachnoid Hemorrhage-Induced Early Brain Injury;Frontiers in Aging Neuroscience;2022-04-29

5. BIIB093 (intravenous glibenclamide) for the prevention of severe cerebral edema;Surgical Neurology International;2021-03-02